To coincide with their recent publication in Nature Communications, the superstar team from the Mercer lab and BASE mRNA Facility at AIBN have announced a new research partnership with Oxford Nanopore Technologies. This partnership will build on the approach developed in collaboration with GIH to streamline and improve quality control and analysis of mRNA vaccines. The partnership will focus on further improving QC workflows, providing robust, real-time analysis of the mRNA manufacturing pipeline to support the rapid development of effective vaccines and therapeutics worldwide.
Read more on the Nanopore website.
Congratulations to Tim, Helen and the rest of the team!
